# The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin A

> **NCT06101433** · NA · COMPLETED · sponsor: **Ahvaz Jundishapur University of Medical Sciences** · enrollment: 46 (actual)

## Conditions studied

- NAFLD

## Interventions

- **DIETARY_SUPPLEMENT:** Soy isoflavone
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06101433
- **Lead sponsor:** Ahvaz Jundishapur University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-06
- **Primary completion:** 2023-03-12
- **Final completion:** 2023-05-11
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2023-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06101433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06101433, "The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin A". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT06101433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*